Chester County News and Community Website
WASHINGTON, D.C. — In a sweeping series of moves that could reshape federal oversight of education, mining safety, labor rights, and the national workforce landscape, the U.S. Department of Labor …
Federal Shake-Up Unleashes Stunning Power Shift—What It Means for America Read More
WEST CHESTER, PA — Chester County officials have appointed a veteran federal communications strategist to lead the county’s public information efforts, selecting Andrew Kreider — a longtime U.S. Environmental Protection …
Chester County Taps Former EPA Leader as New Communications Chief Read More
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as the first-ever treatment for adults with …
FDA Approves First Treatment for High-Risk Smoldering Multiple Myeloma Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced that the Centers for Medicare & Medicaid Services (CMS) will maintain and increase reimbursement for excimer laser procedures through 2026, …
STRATA Secures Medicare Boost as CMS Upholds and Expands Excimer Laser Coverage Read More
WASHINGTON, D.C. — The U.S. Department of Energy announced Thursday a $625 million investment to renew its five National Quantum Information Science Research Centers, reaffirming President Trump’s push to keep …
U.S. Invests $625 Million to Cement Leadership in Quantum Technology Race Read More
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients …
GSK Wins FDA Approval for Blenrep Combo in Advanced Multiple Myeloma Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced a sweeping set of reforms and enforcement actions last week aimed at lowering prescription drug costs and protecting children from …
FDA Cracks Down on Unapproved Fluoride Drugs, Fast-Tracks Cheaper Biologic Alternatives Read More
WASHINGTON, D.C. — The U.S. Department of Labor announced a sweeping series of workforce and safety initiatives last week, including more than $86 million in grants to strengthen state training …
Labor Department Invests $86 Million in Workforce Training, Expands Mine Safety Grants Read More
WILMINGTON, DE — AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to their supplemental Biologics License Application (sBLA) for …
FDA Grants Priority Review for ENHERTU Combo in Advanced Breast Cancer Read More
KING OF PRUSSIA, PA — SEED Therapeutics, Inc. announced it has closed a $30 million Series A-3 financing and received U.S. Food and Drug Administration clearance of its Investigational New …
SEED Therapeutics Secures $30M Funding, Gains FDA Clearance for Lead Drug Read More